652 Results

People

  1. Offit
    Offit
  2. Orlow
    Orlow
  3. Cordon-Cardo
    Cordon-Cardo
  4. Ladanyi
    Ladanyi
  5. Olson
    Olson
  6. Begg
    Begg
  7. Robson
    Robson
  8. Levine
    Levine
  9. Dupont
    Dupont
  10. Kirchhoff
    Kirchhoff

Groups

  1. GSK Faculty (258)
  2. Department of Medicine (252)
  3. Population Sciences Research Program (160)
  4. Solid Tumor Oncology Division (152)
  5. Sloan Kettering Institute Faculty (144)
  6. Department of Pathology and Laboratory Medicine (135)
  7. Epidemiology and Biostatistics (132)
  8. Survivorship Research (116)
  9. Surgery (110)
  10. Tow Center for Developmental Oncology (TCDO) (108)
  1. "genotype"
Formats
  1. Journal Article (627)
  2. Review (9)
  3. Meeting Abstract (6)
  4. Research Letter (5)
  5. Editorial (2)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. GSK Faculty (258)
  2. Department of Medicine (252)
  3. Population Sciences Research Program (160)
  4. Solid Tumor Oncology Division (152)
  5. Sloan Kettering Institute Faculty (144)
  6. Department of Pathology and Laboratory Medicine (135)

More Groups

People
  1. Kenneth Offit (62)
  2. Irene Orlow (38)
  3. Carlos Cordon-Cardo (28)
  4. Marc Ladanyi (27)
  5. Sara Olson (24)
  6. Colin Begg (22)

More People

Years
  1. 2025 (16)
  2. 2024 (29)
  3. 2023 (14)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (24)

More Years

Publications
  1. Clinical Cancer Research (31)
  2. Proceedings of the National Academy of Sciences of the United States of America (24)
  3. Cancer Epidemiology Biomarkers and Prevention (22)
  4. Cancer Research (22)
  5. Nature Genetics (21)
  6. JNCI: Journal of the National Cancer Institute (13)

More Publications

Publishers
  1. American Association for Cancer Research (86)
  2. Nature Publishing Group (78)
  3. Elsevier Inc. (57)
  4. Oxford University Press (38)
  5. Wiley Blackwell (33)
  6. Springer (32)

More Publishers

Results (652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genome-wide analysis of serum platinum levels after cisplatin-based chemotherapy
    Journal Article

    Trendowski, M. R.; El-Charif, O.; Ratain, M. J.; Monahan, P.; Mu, Z.; Wheeler, H. E.; Dinh, P. C. Jr; Feldman, D. R.; Ardeshir-Rouhani-Fard, S.; Hamilton, R. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Diversification and evolution of vancomycin-resistant Enterococcus faecium during intestinal domination
    Journal Article

    Dubin, K. A.; Mathur, D.; McKenney, P. T.; Taylor, B. P.; Littmann, E. R.; Peled, J. U.; Van Den Brink, M. R. M.; Taur, Y.; Pamer, E. G.; Xavier, J. B.
    Infection and Immunity (2019)

    Fulltext@MSK | Save
  • Tumor genomic alterations in severe-combined immunodeficiency bare-lymphocyte syndrome genes are associated with high mutational burden and disproportional neo-antigen rates
    Journal Article

    Wang, Y.; Johnson, D. B.; Lu, S.; Diaz, L. A. Jr; Xu, Y.; Balko, J. M.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Analysis of single nucleotide polymorphisms in the gamma block of the major histocompatibility complex in association with clinical outcomes of hematopoietic cell transplantation: A Center for International Blood and Marrow Transplant Research study
    Journal Article

    Askar, M.; Sayer, D.; Wang, T.; Haagenson, M.; Spellman, S. R.; Lee, S. J.; Madbouly, A.; Fleischhauer, K.; Hsu, K. C.; Verneris, M. R.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Efficacy of MEK inhibition in patients with histiocytic neoplasms
    Journal Article

    Diamond, E. L.; Durham, B. H.; Ulaner, G. A.; Drill, E.; Buthorn, J.; Ki, M.; Bitner, L.; Cho, H.; Young, R. J.; Francis, J. H.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Phf6 loss enhances HSC self-renewal driving tumor initiation and leukemia stem cell activity in T-ALL
    Journal Article

    Wendorff, A. A.; Quinn, S. A.; Rashkovan, M.; Madubata, C. J.; Ambesi-Impiombato, A.; Litzow, M. R.; Tallman, M. S.; Paietta, E.; Paganin, M.; Basso, G.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • p53 represses the mevalonate pathway to mediate tumor suppression
    Journal Article

    Moon, S. H.; Huang, C. H.; Houlihan, S. L.; Regunath, K.; Freed-Pastor, W. A.; Morris, J. P. 4th; Tschaharganeh, D. F.; Kastenhuber, E. R.; Barsotti, A. M.; Culp-Hill, R.; more...
    Cell (2019)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Inherited genetic variants associated with melanoma BRAF/NRAS subtypes
    Journal Article

    Thomas, N. E.; Edmiston, S. N.; Orlow, I.; Kanetsky, P. A.; Luo, L.; Gibbs, D. C.; Parrish, E. A.; Hao, H.; Busam, K. J.; Armstrong, B. K.; more...
    Journal of Investigative Dermatology (2018)

    Fulltext@MSK | Save
  • A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice
    Journal Article

    Morgani, S. M.; Saiz, N.; Garg, V.; Raina, D.; Simon, C. S.; Kang, M.; Arias, A. M.; Nichols, J.; Schröter, C.; Hadjantonakis, A. K.
    Developmental Biology (2018)

    Fulltext@MSK | Save